Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.49
+0.07 (0.94%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $206.74 million as of August 10, 2026. Its market cap has increased by 287.62% in one year.
Market Cap
206.74M
Enterprise Value
147.29M
1-Year Change
287.62%
Ranking
Category
Stock Price
$7.49
ChartMarket Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $206.74M, a decrease of -75.82%. That is a compound annual growth rate of -17.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 206.74M | 106.45% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 213.58M |
| Atrium Therapeutics | 211.08M |
| Greenwich LifeSciences | 210.78M |
| Arcturus Therapeutics Holdings | 210.61M |
| NovaBridge Biosciences | 202.38M |
| Cellectis | 202.28M |
| Voyager Therapeutics | 201.49M |
| Minerva Neurosciences | 198.93M |